Clinical Trial Update: Bacillus Calmette-guérin Vaccination to Prevent COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 trial update on Bacillus Calmette-Guérin vaccination to prevent COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Virus Diseases

Drugs mentioned

• Bacillus Calmette-Guérin (Bacillus Calmette-Guérin)

Snippet

Sponsor: Hellenic Institute for the Study of Sepsis | Conditions: COVID-19, Virus Diseases | Phase 4 | Status: COMPLETED